SEARCH

SEARCH BY CITATION

References

  • 1
    Iung B, Baron G, Butchart EG et al. A prospective survey of patients with valvular heart disease in Europe: the Euro heart survey on valvular heart disease. Eur Heart J 2003; 24: 123143.
  • 2
    Nightingale AK, Horowitz JD. Aortic sclerosis: not an innocent murmur but a marker of increased cardiovascular risk. Heart 2005; 91: 138993.
  • 3
    Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 1999; 341: 1427.
  • 4
    Branch KR, O’Brien KD, Otto CM. Aortic valve sclerosis as a marker of active atherosclerosis. Curr Cardiol Rep 2002; 4: 1117.
  • 5
    Kuusisto J, Räsänen K, Särkioja T, Alarakkola E, Kosma VM. Atherosclerosis-like lesions of the aortic valve are common in adults of all ages: a necropsy study. Heart 2005; 91: 57682.
  • 6
    Erikssen J. Aspects of Latent Coronary Heart Disease. A Prevalence- and Methodological Validation Study in Apparently Healthy, Working Middle Aged Men. Oslo, Norway: University Hospital (Rikshospitalet), Medical Departement B, 1978.
  • 7
    Erikssen J, Enge I, Forfang K, Storstein O. False positive diagnostic tests and coronary angiographic findings in 105 presumably healthy males. Circulation 1976; 54: 3716.
  • 8
    Mundal R, Kjeldsen SE, Sandvik L, Erikssen G, Thaulow E, Erikssen J. Exercise blood pressure predicts mortality from myocardial infarction. Hypertension 1996; 27: 3249.
  • 9
    Åstrand I, Areskog NH, Carlsten A et al. The “Minnesota Code” for ECG classification. Adaptation to CR leads and modification of the code for ECGs recorded during and after exercise by the Scandinavian Committee on ECG Classification. Acta Med Scand Suppl 1967; 481: 126.
  • 10
    Pyörälä K, De Backer G, Graham I, Poole-Wilson P, Wood D. Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Eur Heart J 1994; 15: 130031.
  • 11
    Sandvik L, Erikssen J, Thaulow E, Erikssen G, Mundal R, Rodahl K. Physical fitness as a predictor of mortality among healthy, middle-aged Norwegian men. N Engl J Med 1993; 328: 5337.
  • 12
    SAS. JMP 8 User Guide. Cary, NC, USA: SAS Publishing, 2008.
  • 13
    Stewart BF, Siscovick D, Lind BK et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 1997; 29: 6304.
  • 14
    Dey DK, Sundh V, Steen B. Do systolic murmurs predict mortality in the elderly? A 15-year longitudinal population study of 70-year-olds Arch Gerontol Geriatr 2004; 38: 191200.
  • 15
    Aronow WS, Ahn C, Shirani J, Kronzon I. Comparison of frequency of new coronary events in older subjects with and without valvular aortic sclerosis. Am J Cardiol 1999; 83: 599600. A8.
  • 16
    Taylor Jr HA, Clark BL, Garrison RJ et al. Relation of aortic valve sclerosis to risk of coronary heart disease in African-Americans. Am J Cardiol 2005; 95: 4014.
  • 17
    Lindroos M, Kupari M, Valvanne J, Strandberg T, Heikkilä J, Tilvis R. Factors associated with calcific aortic valve degeneration in the elderly. Eur Heart J 1994; 15: 86570.
  • 18
    Messika-Zeitoun D, Bielak LF, Peyser PA et al. Aortic valve calcification. Determinants and progression in the population. Arterioscler Thromb Vasc Biol 2007; 27: 642648.
  • 19
    Chan KL, Teo K, Dumesnil JG, Ni A, Tam J. Effect of Lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (Astronomer) trial. Circulation 2010; 121: 30614.
  • 20
    Cowell SJ, Newby DE, Prescott RJ et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med 2005; 352: 238997.
  • 21
    Dichtl W, Alber HF, Feuchtner GM et al. Prognosis and risk factors in patients with asymptomatic aortic stenosis and their modulation by atorvastatin (20 mg). Am J Cardiol 2008; 102: 7438.
  • 22
    Rossebø AB, Pedersen TR, Boman K et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med 2008; 359: 134356.
  • 23
    Bodegard J, Erikssen G, Björnholt JV, Gjesdal K, Thelle D, Erikssen J. Symptom-limited exercise testing, ST depressions and long-term coronary heart disease mortality in apparently healthy middle-aged men. Eur J Cardiovasc Prev Rehabil 2004; 11: 3207.
  • 24
    Poggianti E, Venneri L, Chubuchny V, Jambrik Z, Baroncini LA, Picano E. Aortic valve sclerosis is associated with systemic endothelial dysfunction. J Am Coll Cardiol 2003; 41: 13641.
  • 25
    Walsh CR, Larson MG, Kupka MJ et al. Association of aortic valve calcium detected by electron beam computed tomography with echocardiographic aortic valve disease and with calcium deposits in the coronary arteries and thoracic aorta. Am J Cardiol 2004; 93: 4215.
  • 26
    Beppu S, Suzuki S, Matsuda H, Ohmori F, Nagata S, Miyatake K. Rapidity of progression of aortic stenosis in patients with congenital bicuspid aortic valves. Am J Cardiol 1993; 71: 3227.
  • 27
    Pachulski RT, Chan KL. Progression of aortic valve dysfunction in 51 adult patients with congenital bicuspid aortic valve: assessment and follow up by Doppler echocardiography. Br Heart J 1993; 69: 23740.